Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Pryce

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 15, 2013
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonistsGareth Pryce, Cristina Visintin, Sreeram V Ramagopalan, et al.
Brain : a Journal of Neurology|November 30, 2013
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosisSarah Al-Izki, Gareth Pryce, Deborah J R Hankey, et al.
British Journal of Pharmacology|July 6, 2017
Big conductance calcium-activated potassium channel openers control spasticity without sedationDavid Baker, Gareth Pryce, Cristina Visintin, et al.
Neuropathology and Applied Neurobiology|October 1, 2022
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosisSimon Licht-Mayer, Graham R Campbell, Arpan R Mehta, et al.
Acta Neuropathologica|June 24, 2020
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosisSimon Licht-Mayer, Graham R Campbell, Marco Canizares, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 15, 2013
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonistsGareth Pryce, Cristina Visintin, Sreeram V Ramagopalan, et al.
Brain : a Journal of Neurology|November 30, 2013
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosisSarah Al-Izki, Gareth Pryce, Deborah J R Hankey, et al.
British Journal of Pharmacology|July 6, 2017
Big conductance calcium-activated potassium channel openers control spasticity without sedationDavid Baker, Gareth Pryce, Cristina Visintin, et al.
Neuropathology and Applied Neurobiology|October 1, 2022
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosisSimon Licht-Mayer, Graham R Campbell, Arpan R Mehta, et al.
Acta Neuropathologica|June 24, 2020
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosisSimon Licht-Mayer, Graham R Campbell, Marco Canizares, et al.
Pageof 7